Polares Medical is an early and clinical-stage medical device company working on developing a technology that can address mitral valve regurgitation: a common cardiovascular disease. The company is based in Switzerland with Ra large office in Palo Alto, California. The company spun-out of Symetis (acquired by Boston Scientific) which developed a technology to treat aortic valve stenosis, to fully concentrate its efforts on the mitral valve of the heart.
Polares is currently developing a passive implant that would serve not as a repair nor a replacement of the Mitral Valve (MV) but as a partial replacement, which is a fast and cost-effective treatment than the current offering
With the devices is potential, IDO is discussing with various stakeholders how to gain first access and make the technology readily available to the Omani population after regulatory approvals are attained.
IDO Value Add
Polares’ device is in clinical trials, nevertheless there is an opportunity for Omani physicians to travel to Europe to participate and learn from the ongoing trials. This knowledge exchange is a unique learning opportunity for Omani doctors, which will enrich the medical innovation and research done locally, as well as offer Polares a new set of minds to contribute to the development and success of the product.